Sarepta Therapeutics (NASDAQ:SRPT) Cut to “Hold” at TD Cowen
TD Cowen downgraded shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) from a buy rating to a hold rating in a research report released on Wednesday, Marketbeat reports. TD Cowen currently has $24.00 price target on the biotechnology company’s stock. Several other equities research analysts have also issued reports on SRPT. Wolfe Research started coverage […]
TD Cowen downgraded shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) from a buy rating to a hold rating in a research report released on Wednesday, Marketbeat reports. TD Cowen currently has $24.00 price target on the biotechnology company’s stock. Several other equities research analysts have also issued reports on SRPT. Wolfe Research started coverage […]
